4,217
Views
33
CrossRef citations to date
0
Altmetric
Reports

CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors

, , , , , , , , , , , , , , , , , , , & show all
Pages 436-453 | Received 29 Jun 2015, Accepted 06 Nov 2015, Published online: 28 Jan 2016